Drug firms demand NPPA withdraw notices alleging overchargingPost published:August 30, 2017Post category:Industry NewsThe Indian Pharmaceutical Alliance has written to the pharma dept criticizing NPA for issuing demand notices to top drug makers over ‘suspected overcharging’ Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostSBI gears up for expected surge in affordable housing loan demand Next PostInfosys to start work on Kolkata centre: Mamata Banerjee You Might Also Like Aerojet Rocketdyne Acquires 3D Material Technologies and Expands Metal Additive Manufacturing Capabilities April 5, 2019 Ainstein Introduces New Lineup of IoT Radar Modules January 14, 2020 Zuken, CADENAS and ECAD-Port announce component library cooperation November 26, 2018
Aerojet Rocketdyne Acquires 3D Material Technologies and Expands Metal Additive Manufacturing Capabilities April 5, 2019